ERBB2 and neoplasm: A major drawback of utilizing liquid biopsies for patient stratification is that although they provide fast, minimally invasive, and cost-effective diagnostic insights, they will not visualize disease localization, tumor heterogeneity, or the extent of HER2-expression within patients and are, from this aspect, inferior to molecular imaging approaches.